Status | Study |
Completed |
Study Name: European Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS) Condition: Lennox-Gastaut Syndrome Date: 2013-11-18 |
Terminated |
Study Name: Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Condition: Epilepsy Date: 2012-05-17 Interventions: Drug: retigabine/ezogabine retigabine/ezogabine will be administered three times a day (TID) as add-on t |
Terminated |
Study Name: Study in Pediatric Subjects With Epilepsy Condition: Epilepsy Date: 2011-12-01 Interventions: Drug: ezogabine/retigabine ezogabine dose escalation |
Completed |
Study Name: Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs Condition: Lennox-Gastaut Syndrome Date: 2011-07-27 Interventions: Drug: Rufinamide rufinamide up |
Completed |
Study Name: Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects Condition: Lennox-Gastaut Syndrome Date: 2011-06-08 Interventions: Drug: melatonin melatonin cp 2 |
Completed |
Study Name: Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome Condition: Lennox-Gastaut Syndrome Date: 2010-06-18 Interventions: Drug: Clobazam Clobazam will be provided in 5 mg, 10 mg and 20 mg tablets and will be dispensed in bottl |
Completed |
Study Name: A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304) Condition: Lennox-Gastaut Syndrome Date: 2010-06-14 Interventions: Drug: Rufinamide (E2080) |
Completed |
Study Name: A Long Term Extension Study of E2080 in Lennox-Gastaut Patients Condition: Lennox-Gastaut Syndrome Date: 2010-06-14 Interventions: Drug: E2080 The target dosage is approximately 45 mg/kg/day, taken orally twice a day. |
Completed |
Study Name: Clobazam in Patients With Lennox-Gastaut Syndrome Condition: Epilepsy Epilepsy, Generalized Seizures Date: 2007-08-20 Interventions: Drug: Clobazam Low Dose 0.25 m |
Completed |
Study Name: A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures Condition: Seizures Epilepsy Date: 2006-02-24 Interventions: Drug: Topiramate Individualization of the treatment should begin from 25 mg for 1 week. |